RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MAGNI M
Collezione AOU Città della Salute di Torino

Items : 5

Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study. in British journal of haematology / Br J Haematol. 2025 Feb;206(2):644-651. doi: 10.1111/bjh.19961. Epub 2024 Dec 22.

2025
AOU Città della Salute di Torino

Sorà F; Zinzani P; Tisi MC; Arcaini L; Krampera M; Patriarca F; Botto B; Angelillo P; Grillo G; Massaia M; Martino M; Farina M; Barbui AM; Cutini I; Ljevar S; Musso M; De Philippis C; Bonifazi F; Magni M; Chiappella A; Stella F; Bramanti S; Pennisi M; Carniti C; Corradini P;

Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. in Leukemia / Leukemia. 2024 May;38(5):1107-1114. doi: 10.1038/s41375-024-02213-x. Epub 2024 Mar 8.

2024
AOU Alessandria
AOU Città della Salute di Torino

Corradini P; Zinzani PL; Miceli R; Guidetti A; Saccardi R; Bermema A; Ferrari S; Martelli M; Ferreri AJM; Pennisi M; Galli E; Patriarca F; Zacchi G; Krampera M; Grillo G; Novo M; Martino M; Farina M; Musso M; Tisi MC; Bramanti S; Bonifazi F; Dodero A; Cutini I; Angelillo P; Barbui AM; Ljevar S; Magni M; Di Rocco A; et alii...

Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas. in British journal of haematology / Br J Haematol. 2024 May;204(5):1752-1756. doi: 10.1111/bjh.19280. Epub 2024 Jan 4.

2024
AOU Città della Salute di Torino

Pinto A; Rossi FG; Castellino C; Stefoni V; Usai SV; Re A; Orsucci L; Ljevar S; Dodero A; Caldarelli N; Chiappella A; Magni M; Zanirato G; Fardella E; Carniti C; Corradini P;

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Oct;56(10):2606-2609. doi: 10.1038/s41409-021-01391-x. Epub 2021 Jul 7.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Corradini P; Magni M; Ladetto M; Ferrero S; Rossi A; Barbui AM; Tarella C; Rambaldi A; Rigacci L; Gianni AM; Castellino C; Nicoli P; Ferreri AJM; Chiappella A; Benedetti F; Vitolo U; Patti C; Costa A; Evangelista A; Devizzi L; Mian M; Cortelazzo S;

CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). in Haematologica / Haematologica. 2021 Nov 1;106(11):2918-2926. doi: 10.3324/haematol.2020.262659.

2021
AOU Città della Salute di Torino

Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P;